(Q30659915)

26 June 2017

Efficacy of interferon alfa-2a in severe and refractory uveitis associated with Behçet's disease (English)

1 reference

26 June 2017

0 references

0 references

P LeHoang

8

0 references

Bahram Bodaghi

object named as

B Bodaghi

2

0 references

Zahir Amoura

5

object named as

Z Amoura

1 reference

26 June 2017

7

J C Piette

1 reference

26 June 2017

B Wechsler

1

1 reference

26 June 2017

D L Huong

3

1 reference

26 June 2017

C Fardeau

4

1 reference

26 June 2017

N Cassoux

6

1 reference

26 June 2017

language of work or name

1 reference

1 December 2000

1 reference

Ocular Immunology and Inflammation

26 June 2017

1 reference

26 June 2017

8

1 reference

26 June 2017

293-301

1 reference

26 June 2017

4

1 reference

Cyclosporin-A therapy in severe uveitis of Behçet's disease.

26 June 2017

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Azathioprine in Behcet's syndrome: effects on long-term prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Treatment of ocular symptoms of Behçet's disease with interferon alpha 2a: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

New concepts in treatment protocols for severe systemic vasculitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Efficacy and safety of systemic recombinant interferon-alpha in Behçet's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Interferon alfa-2a in the treatment of Behçet's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Retinopathy and subconjunctival haemorrhage in patients with chronic viral hepatitis receiving interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Study of the association between major histocompatibility complex class II genes and the response to interferon alpha in patients with chronic hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

Viral and host factors in the prediction of response to interferon-alpha therapy in chronic hepatitis C after long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1076%2FOCII.8.4.293.6453

10.1076/OCII.8.4.293.6453

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference